Evaluating the cost-effectiveness of [ 18 F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients.

Michelle TewAbby P DouglasJeff SzerAshish BajelSimon J HarrisonShio Yen TioLeon J WorthRodney J HicksDavid RitchieMonica A SlavinKarin A ThurskyKim Dalziel

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)

This trial is registered with ClinicalTrials.gov, NCT03429387.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
clinical trial
prognostic factors
open label